BR9610316A - Composto processo para a produção e uso do mesmo processo para o tratamento de doença das vias aéreas e composição farmacêutica - Google Patents

Composto processo para a produção e uso do mesmo processo para o tratamento de doença das vias aéreas e composição farmacêutica

Info

Publication number
BR9610316A
BR9610316A BR9610316A BR9610316A BR9610316A BR 9610316 A BR9610316 A BR 9610316A BR 9610316 A BR9610316 A BR 9610316A BR 9610316 A BR9610316 A BR 9610316A BR 9610316 A BR9610316 A BR 9610316A
Authority
BR
Brazil
Prior art keywords
treatment
production
pharmaceutical composition
airway disease
same process
Prior art date
Application number
BR9610316A
Other languages
English (en)
Inventor
Roger Victor Bonnert
Roger Charles Brown
Peter Alan Cage
Francis Ince
Garry Pairaudeau
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9518952.8A external-priority patent/GB9518952D0/en
Priority claimed from GBGB9614346.6A external-priority patent/GB9614346D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of BR9610316A publication Critical patent/BR9610316A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
BR9610316A 1995-09-15 1996-09-12 Composto processo para a produção e uso do mesmo processo para o tratamento de doença das vias aéreas e composição farmacêutica BR9610316A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9518952.8A GB9518952D0 (en) 1995-09-15 1995-09-15 Compounds
GBGB9614346.6A GB9614346D0 (en) 1996-07-10 1996-07-10 Benzothiazolone derivatives
PCT/GB1996/002247 WO1997010227A1 (en) 1995-09-15 1996-09-12 Benzothiazolone derivatives

Publications (1)

Publication Number Publication Date
BR9610316A true BR9610316A (pt) 1999-07-06

Family

ID=26307771

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610316A BR9610316A (pt) 1995-09-15 1996-09-12 Composto processo para a produção e uso do mesmo processo para o tratamento de doença das vias aéreas e composição farmacêutica

Country Status (29)

Country Link
US (5) US5846989A (pt)
EP (1) EP0850232B1 (pt)
JP (1) JP3213327B2 (pt)
KR (1) KR19990044674A (pt)
CN (2) CN1073098C (pt)
AR (1) AR004512A1 (pt)
AT (1) ATE190610T1 (pt)
AU (1) AU706094B2 (pt)
BR (1) BR9610316A (pt)
CA (1) CA2231003A1 (pt)
CY (1) CY2227B1 (pt)
CZ (1) CZ74098A3 (pt)
DE (1) DE69607183T2 (pt)
EE (1) EE03395B1 (pt)
ES (1) ES2146901T3 (pt)
GR (1) GR3033681T3 (pt)
HK (1) HK1008781A1 (pt)
HU (1) HUP9802393A3 (pt)
IL (4) IL141955A0 (pt)
IS (1) IS4679A (pt)
MY (1) MY113518A (pt)
NO (1) NO310721B1 (pt)
NZ (4) NZ318007A (pt)
PL (1) PL325517A1 (pt)
PT (1) PT850232E (pt)
SK (1) SK282394B6 (pt)
TR (1) TR199800457T2 (pt)
TW (1) TW356468B (pt)
WO (1) WO1997010227A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5187991B2 (ja) * 1997-10-17 2013-04-24 アーク・セラピューティックス・リミテッド レニン−アンジオテンシン系の阻害剤の使用
SE0004750D0 (sv) * 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
AR040962A1 (es) * 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
CN100569760C (zh) * 2003-11-21 2009-12-16 施万制药 具有β2肾上腺素能受体激动剂和毒蕈碱性受体拮抗剂活性的化合物
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
TW200738658A (en) * 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
CN101282950B (zh) * 2005-08-09 2012-09-12 阿斯利康(瑞典)有限公司 新颖的苯并噻唑酮衍生物
TW200740781A (en) * 2005-08-29 2007-11-01 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) * 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
US20100056508A1 (en) * 2006-12-20 2010-03-04 Astrazeneca Ab Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
UY31905A (es) 2008-06-18 2010-01-29 Astrazeneca Ab Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
WO2009154562A1 (en) * 2008-06-20 2009-12-23 Astrazeneca Ab Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
DK514585A (da) * 1984-11-08 1986-05-09 Syntex Inc Aminoethylanilinderivater
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds

Also Published As

Publication number Publication date
DE69607183D1 (de) 2000-04-20
EE9800069A (et) 1998-10-15
EP0850232A1 (en) 1998-07-01
NO981104D0 (no) 1998-03-12
CA2231003A1 (en) 1997-03-20
CN1356323A (zh) 2002-07-03
PT850232E (pt) 2000-08-31
NZ332395A (en) 1999-02-25
KR19990044674A (ko) 1999-06-25
IL123639A (en) 2002-04-21
WO1997010227A1 (en) 1997-03-20
EP0850232B1 (en) 2000-03-15
US6008365A (en) 1999-12-28
HUP9802393A3 (en) 2000-01-28
HUP9802393A2 (hu) 1999-04-28
ATE190610T1 (de) 2000-04-15
NO310721B1 (no) 2001-08-20
SK282394B6 (sk) 2002-01-07
PL325517A1 (en) 1998-08-03
AR004512A1 (es) 1998-12-16
JP3213327B2 (ja) 2001-10-02
ES2146901T3 (es) 2000-08-16
TW356468B (en) 1999-04-21
GR3033681T3 (en) 2000-10-31
CN1073098C (zh) 2001-10-17
SK29598A3 (en) 1999-01-11
US5846989A (en) 1998-12-08
CN1202163A (zh) 1998-12-16
AU6937196A (en) 1997-04-01
AU706094B2 (en) 1999-06-10
IL141955A0 (en) 2002-03-10
NZ318007A (en) 1999-07-29
IS4679A (is) 1998-03-04
TR199800457T2 (xx) 1998-07-21
IL123639A0 (en) 1998-10-30
CY2227B1 (en) 2003-04-18
JPH11512422A (ja) 1999-10-26
IL141954A0 (en) 2002-03-10
US5977384A (en) 1999-11-02
IL141956A0 (en) 2002-03-10
US6080869A (en) 2000-06-27
NO981104L (no) 1998-05-14
US5973167A (en) 1999-10-26
MY113518A (en) 2002-03-30
NZ332396A (en) 1999-02-25
CZ74098A3 (cs) 1998-08-12
EE03395B1 (et) 2001-04-16
HK1008781A1 (en) 1999-05-21
DE69607183T2 (de) 2000-11-23
NZ332397A (en) 1999-02-25
MX9801963A (es) 1998-08-30

Similar Documents

Publication Publication Date Title
BR9503812A (pt) Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto
BR9609780A (pt) Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto
BR9602542A (pt) Composto método para o tratamento de uma doença dependente da fosforilase de glicogénio composição farmacéutica e processo para a preparação de um composto
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
BR9612204A (pt) Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor
BR9609701A (pt) Composição farmacéutica composto e processo para a preparação de compostos
PT820276E (pt) Processo para a preparacao de particulas respiraveis
EE9600019A (et) 2,8-diasendatud kinasolinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
BR9503638A (pt) Composto processo para sua produção e formulação farmacêutica
BR9506026A (pt) Pérolas de liberação controlada processo para a preparação das mesmas preparação farmacêutica processo para a fabricação da mesma uso das pérolas de liberação controlada e processo para o tratamento da hipertensão de edemas e da falha congestiva do coração
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
EE9700031A (et) Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
EE9700019A (et) 2-okso- ja 2-tio1,2-dihüdrokinolinüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
BR9601028A (pt) Compostos processo para sua preparação processo para a produção de preparações farmacêuticas preparação farmacêutica medicamento e uso
BR9601093A (pt) Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização
BR9707489A (pt) Composto composição farmacêutica e processo para tratar um paciente sofrendo de um distúrbio fisilógico
BR9605354A (pt) Composto composição farmacêutica processo para a produção do composto e uso
BR9506473A (pt) Composto processo para a preparação de compostos utilização de um composto composição farmacêutica e processo para o tratamento de infecções anti-fúngicas
BR9610316A (pt) Composto processo para a produção e uso do mesmo processo para o tratamento de doença das vias aéreas e composição farmacêutica
BR9502471A (pt) Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica
BR9602150A (pt) Compostos processo para sua preparação processo para a produção de uma formulação farmacêutica formulação farmacêutica e uso
BR9505610A (pt) Composto composição farmacéutica processo para a preparação de um composto uso e método de tratar inflamação e dor
BR9601275A (pt) Compostos processo para sua preparação medicamentos preparação farmacêutica processo para sua produção e uso
BR9708607A (pt) Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico

Legal Events

Date Code Title Description
PC Transfer

Free format text: ASTRAZENECA AB (SE)

EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal